Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1
And if you are using protein shakes for GLP-1 , our guide covers the best options and timing strategies
Research Findings on L-Carnitine for Insulin Resistance Early research has investigated how L-Carnitine supplementation might help manage insulin resistance
BMI and season are associated with vitamin D deficiency in women with impaired fertility: a two-centre analysis
"People often think that there's some magic pill, or some sick special diet, or exercise regime or whatever," she said
Mutations in KRAS lead to the upregulation of the expression of the SLC7A5, SLC38A2, and SLC25A22 transporters in cancer cells, thereby promoting glutamine uptake [50]